Clinical Trial Details
| Trial ID: | L0204 |
| Source ID: | NCT01717248 |
| Associated Drug: | Gcs-100 |
| Title: | Safety Study of GCS-100 to Treat Chronic Kidney Disease |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Chronic Kidney Disease |
| Interventions: | DRUG: GCS-100 |
| Outcome Measures: | Primary: Evaluation of Safety, Assess overall safety of rising dose of GCS-100 in CKD patients, Ongoing | |
| Sponsor/Collaborators: | Sponsor: La Jolla Pharmaceutical Company |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE1 |
| Enrollment: | 29 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2013-01 |
| Completion Date: | 2013-06 |
| Results First Posted: | |
| Last Update Posted: | 2013-06-20 |
| Locations: | Southwest Clinical Research Institute, Tempe, Arizona, 85284, United States|California Institue of Renal Research, La Mesa, California, 91942, United States|Denver Nephrologists, PC, Denver, Colorado, 80230, United States|Renal Associates PA / Research Division, San Antonio, Texas, 78215, United States |
| URL: | https://clinicaltrials.gov/show/NCT01717248 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|